Navigation Links
Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors
Date:10/15/2007

its sites worldwide in innovative and unique products with high added value. Yehudai noted, "The acquisition of Gewurzmuller, following the acquisition of Nesse last year, is another milestone in developing and strengthening Frutarom's savory activity, and we intend to continue investing in this important market segment. The Blessing Biotech activity opens up for Frutarom an innovative and fascinating field that is at the technological forefront of ingredients with the greatest added value for manufacturing food products."

Yehudai added, "Thanks to Frutarom's proven experience in making acquisitions and in realizing the synergy and cross selling opportunities, we are convinced that this acquisition will benefit Frutarom's continued fast growth and profitability and will create added value for our customers, our employees and our investors."

Frutarom's personnel in the fields of unique savory flavors and functional ingredients will benefit from the significant addition of experienced and skilled employees at all levels. The Gewurzmuller Group's strong, experienced management, including the Rendlen family (the sellers), will be integrated into Frutarom's and together lead the activity in Europe and Frutarom's global savory activity. The Gewurzmuller Group has extensive research and development activity, possesses patented products and processes, and collaborates with leading European universities. Frutarom's research and development team will be augmented by skilled, experienced and high quality personnel.

Yehudai added, "Above and beyond the extensive synergy existing in the German market, there is synergy between the Gewurzmuller group's and Frutarom's activity in many additional countries, particularly in the western and eastern European markets. We intend to take advantage of our global marketing and sales infrastructure to leverage and realize the many cross selling opportunities created by this acquisition, by broadening both the customer base
'/>"/>

SOURCE Frutarom Industries Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ossur Acquires the U.S. Orthopaedics Company
2. Stem of Hope: Stem Cell Research Acquires a Brittle Star As A model
3. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
4. Premier Army Hospital Acquires PET-CT Scanner
5. Wockhardt acquires Protinex, Farex brands from Netherland Co
6. Indoco Remedies Acquires La Nova Chem
7. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
8. AIIMS Acquires Four-Armed Robot to Assist in Surgeries
9. Apollos Global Arm Acquires US-based Firm
10. ‘Obesity’ Acquires Permanent Resident Status in the US
11. Indias Wockhardt Acquires Irish Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... Allows Consolidated Access to Interdisciplinary Evidence-based Content throughout the ... ... (PRWEB) December 7, 2009 -- Institutions currently using ... and Zynx Health will benefit from a ... their evidence-based resources, resulting in quicker retrieval of relevant ...
(Date:12/7/2009)... collection agency A.R.M. Solutions was recognized as a leader in ... Solutions, award-winning recovery service outperforms traditional collection agencies in speed, ... ... (PRWEB) December 7, 2009 -- A.R.M. Solutions, a leading provider ... Best Places to Work in Collections by insideARM.com. This is ...
(Date:12/7/2009)... discovered a technique that is able to determine whether ... snoring by screening their urine. , "These findings ... urine test that could detect OSA in snoring children. ... sleep studies in children who snore, only about 20 ... lead author David Gozal, M.D., professor and chairman of ...
(Date:12/6/2009)... San Antonio Bay ,, SILVER SPRING, Md., Dec. ... is advising consumers to avoid eating oysters harvested from ... due to reports of norovirus-associated illnesses in some people ... is located on the Gulf of Texas. ,, ... along with the Centers for Disease Control and Prevention ...
(Date:12/6/2009)... in virus , , SUNDAY, Dec. 6 (HealthDay News) -- Early ... in a tiger that lived thousands or millions of years ... took on a bit of a tiger,s genetic material, scientists ... virus to this day. That tiger, in fact, may have ... that ultimately led to its infection of humans. , The ...
Breaking Medicine News(10 mins):Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 2Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 3Health News:Collection Agency Named One of 2009 Best Places to Work 2Health News:Urine test for pediatric obstructive sleep apnea possible 2Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:AIDS May Date Back to Ancient Tiger 2
... announced on Tuesday that the city has experienced a 37% ... new cases reported// in the first three months of the ... under the Department of Health, which filed the statistics on ... contact. Reviewing the AIDS situation in Hong Kong at a ...
... sudden demise of the Director General of World Health Organization, ... programmes, People's Health Organization (India) said here today.// ,Lee, ... and other deadly diseases, was the first WHO chief to ... S Gilada said., ,PHO's condolence resolution stated that "the ...
... provides protection against flu to the elderly people,// but ... without any major harmful effect. This was published in ... a JAMA/Archives journal. ,Vaccines containing inactivated influenza virus ... and its complications, according to background information in the ...
... distributing condoms in the province would no longer be able ... teenage pregnancies//. The trust said that only authorized staff could ... ,"My concern is that child protection is ... Dean Marshall, deputy chairman of the BMA's Scottish GP committee. ...
... suffer from disrupting sleep and increased blood pressure. But ... breathing masks are very helpful// in giving them an ... pressure significantly. ,The study results were presented at ... have significant consequences on a person's physical health, and ...
... it was found that amino acid, l-cysteine can prevent ... of the cancers occur// in the mouth, pharynx and ... drinking. This results in a strong exposure of the ... research group of Professor Mikko Salaspuro, University of Helsinki ...
Other Medicine News:Health News:Immunity carefully enhanced in elders by high-dose flu vaccines 2Health News:Sleep Apnea Patients Benefit from Breathing Mask 2Health News:Finnish research: Cysteine Chewing Gum as a cure for cancers of the mouth 2
(Date:12/4/2009)... Inc. (NYSE Amex: PIP ), a biodefense company ... today the presentation of new data from the Company,s ... Antigen (rPA) based anthrax vaccine is structurally stable and ... and including 55 degrees C. The data were ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), ... and chemical threats, announced today that the Company ... effectiveness of Valortim® in an inhalation anthrax model ... The data are being presented during an oral ...
(Date:12/4/2009)... 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ... that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated ... Drug Administration seeking approval to market its 8mg ramelteon ... by Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Janet Sartin Expands Line of Products That Reduce and Conceal Eye Puffiness and Fine Lines 51168 1Janet Sartin Expands Line of Products That Reduce and Conceal Eye Puffiness and Fine Lines 51168 2Janet Sartin Expands Line of Products That Reduce and Conceal Eye Puffiness and Fine Lines 51168 3ONRAD Announces New PACS Application Service Provider Model 51165 1ONRAD Announces New PACS Application Service Provider Model 51165 22 reproductive factors are important predictors of death from ovarian cancer 9184 12 reproductive factors are important predictors of death from ovarian cancer 9184 22 reproductive factors are important predictors of death from ovarian cancer 9184 3
... 04, 2007 /PRNewswire-FirstCall/ --,Genta Incorporated announced the ... trial of its marketed product, Ganite(R) (gallium,nitrate ... patients with relapsed or refractory non-Hodgkin's,lymphoma (NHL). ... meeting of,the American Society of Clinical Oncology ...
... Pertuzumab shows promising results in,advanced breast cancer ... BASEL, Switzerland, June 4, 2007-Early clinical results ... medicine pertuzumab, a HER,dimerisation inhibitor, show substantial ... breast cancer, when,combined with Herceptin. The study ...
Other Medicine Technology:Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 2Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 3Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 4Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 5
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 19.0 mm and length 21 mm....
... The BacT/Alert 3D Signature is ... microbial detection system that integrates blood, ... It is a powerful microbiology workstation ... for higher volume identification and where ...
Medicine Products: